Learn to Evaluate (APGE) using the Charts - news.stocktradersdaily.com
2 days ago • Google News
Apogee Therapeutics, Inc. Common Stock (APGE)
US$ 39.89-2.33%
Price Chart
Key Statistics
Market Cap
$ 2.53B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
1.27M
52W High
$ 63.50
52W Low
$ 26.20
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
39.3005
200-Day MA
43.5526
52 Week High
63.5
52 Week Low
26.2
About APGE
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pul.
Employees
196
Headquarters
Waltham, MA
CEO
Dr. Michael Thomas Henderson M.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg